IC Plus Low-dose Radiation Plus Cadonilimab in LANPC

Clinical trial NCT05941741 · RECRUITING

Trial details

NCT number: NCT05941741
Sponsor: Sun Yat-sen University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Nasopharyngeal Carcinoma Immune Checkpoint Inhibitor Radiotherapy Chemotherapy

Start date: 2024-01-10
Primary completion: 2027-12-01
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.